Elisa Benetti

Publication Activity (10 Years)

Years Active: 2015-2022
Publications (10 Years): 6

Top Topics

Insulin Resistance

Top Venues

Oxidative medicine and cellular longevity

The Journal of pharmacology and experimental therapeutics

International journal of molecular sciences

This page only lists publications with an associated author ORCID identifier.

Publications

Valentina Boscaro, Matteo Rivoira, Barbara Sgorbini, Valentina Bordano, Francesca Dadone, Margherita Gallicchio, Aline Pons, Elisa Benetti, Arianna Carolina Rosa
Evidence-Based Anti-Diabetic Properties of Plant from the Occitan Valleys of the Piedmont Alps. Pharmaceutics 14 (11) (2022)
Gemma K Kinsella, Stefania Cannito, Valentina Bordano, John C Stephens, Arianna Carolina Rosa, Gianluca Miglio, Valeria Guaschino, Valeria Iannaccone, John B C Findlay, Elisa Benetti
GPR21 Inhibition Increases Glucose-Uptake in HepG2 Cells. International journal of molecular sciences 22 (19) (2021)
Roberta Verta, Maura Gurrieri, Sara Borga, Elisa Benetti, Paolo Pollicino, Roberta Cavalli, Robin L Thurmond, Paul L Chazot, Alessandro Pini, Arianna Carolina Rosa, Cristina Grange
The Interplay between Histamine H4 Receptor and the Kidney Function: The Lesson from H4 Receptor Knockout Mice. Biomolecules 11 (10) (2021)
Elisa Benetti, Raffaella Mastrocola, Fausto Chiazza, Debora Nigro, Giuseppe D'Antona, Valentina Bordano, Roberto Fantozzi, Manuela Aragno, Massimo Collino, Marco Alessandro Minetto
Effects of vitamin D on insulin resistance and myosteatosis in diet-induced obese mice. PloS one 13 (1) (2018)
Elisa Benetti, Raffaella Mastrocola, Giovanna Vitarelli, Juan Carlos Cutrin, Debora Nigro, Fausto Chiazza, Eric Mayoux, Massimo Collino, Roberto Fantozzi
Empagliflozin Protects against Diet-Induced NLRP-3 Inflammasome Activation and Lipid Accumulation. The Journal of pharmacology and experimental therapeutics 359 (1) (2016)
Fausto Chiazza, Konstantin Chegaev, Mara Rogazzo, Juan C Cutrin, Elisa Benetti, Loretta Lazzarato, Roberta Fruttero, Massimo Collino
A nitric oxide-donor furoxan moiety improves the efficacy of edaravone against early renal dysfunction and injury evoked by ischemia/reperfusion. Oxidative medicine and cellular longevity 2015 (2015)